As a part of the study the antibody responses in sera of 51 participants who received two doses of Covaxin collected six months post second dose and 28 days after receiving a third (booster) dose (given on day 215th post second dose) and its impact against the Omicron VoC was evaluated
Read More
The Serum Institute of India has cut the rates of Covishield from ₹600 to ₹225 per dose, while Bharat Biotech has brought down the price of Covaxin from ₹1,200 to ₹225
Read More
The Centre had announced that the precaution dose of Covid vaccines will be available to everyone aged above 18 years at the private vaccination centres from April 10
Read More
Covax has delivered 1.42 billion doses to 145 countries. Scaling up deliveries through Covax is seen as critical to meeting a WHO target to vaccinate 70 per cent of the population in poorer nations by mid-2022
Read More
Noting that the supply of Covid-19 vaccines is not the issue as manufacturers are producing 1.5 billion doses per month, Guterres said progress in achieving vaccine equity is possible but the window is closing fast
Read More
At present, India is administering the precautionary third dose to priority groups – healthcare workers, frontline workers, and to those aged above 60. This is being administered free of cost at government vaccination centres
Read More
The revenues of homegrown drug firms are expected to moderate from a growth of 8-10 per cent in 2021-22, it stated citing findings from the sample set of sample set of 21 companies
Read More
The state health department said the XE variant is a combination of BA.1 and BA.2 strains of Omicron and was found to be responsible for enhanced viral transmission
Read More
